DE10259506A1 - Appetite-and cholesterol-reducing agent comprises a low esterified polysaccharide and a different material which is swellable - Google Patents
Appetite-and cholesterol-reducing agent comprises a low esterified polysaccharide and a different material which is swellable Download PDFInfo
- Publication number
- DE10259506A1 DE10259506A1 DE10259506A DE10259506A DE10259506A1 DE 10259506 A1 DE10259506 A1 DE 10259506A1 DE 10259506 A DE10259506 A DE 10259506A DE 10259506 A DE10259506 A DE 10259506A DE 10259506 A1 DE10259506 A1 DE 10259506A1
- Authority
- DE
- Germany
- Prior art keywords
- means according
- cellulose
- swellable
- acid
- polysaccharides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 13
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 13
- 150000004676 glycans Chemical class 0.000 title abstract 2
- 239000000463 material Substances 0.000 title abstract 2
- 239000003638 chemical reducing agent Substances 0.000 title 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims abstract description 22
- 230000000694 effects Effects 0.000 claims abstract description 13
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 12
- 235000012000 cholesterol Nutrition 0.000 claims abstract description 6
- 229920002678 cellulose Polymers 0.000 claims description 22
- 235000010980 cellulose Nutrition 0.000 claims description 21
- 239000001913 cellulose Substances 0.000 claims description 18
- 235000010443 alginic acid Nutrition 0.000 claims description 13
- 229920000615 alginic acid Polymers 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 13
- 235000010987 pectin Nutrition 0.000 claims description 12
- 229920001277 pectin Polymers 0.000 claims description 12
- 239000001814 pectin Substances 0.000 claims description 12
- 150000004804 polysaccharides Chemical class 0.000 claims description 11
- 150000001875 compounds Chemical class 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 9
- 239000000783 alginic acid Substances 0.000 claims description 9
- 229960001126 alginic acid Drugs 0.000 claims description 9
- 150000004781 alginic acids Chemical class 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 229920000642 polymer Polymers 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 230000001105 regulatory effect Effects 0.000 claims description 6
- 230000004580 weight loss Effects 0.000 claims description 6
- 239000004480 active ingredient Substances 0.000 claims description 5
- 229920006318 anionic polymer Polymers 0.000 claims description 5
- 230000036186 satiety Effects 0.000 claims description 4
- 235000019627 satiety Nutrition 0.000 claims description 4
- 229940088594 vitamin Drugs 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims description 2
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 claims description 2
- 241000416162 Astragalus gummifer Species 0.000 claims description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 claims description 2
- 229920001615 Tragacanth Polymers 0.000 claims description 2
- 229940059329 chondroitin sulfate Drugs 0.000 claims description 2
- 239000011573 trace mineral Substances 0.000 claims description 2
- 235000013619 trace mineral Nutrition 0.000 claims description 2
- 235000010487 tragacanth Nutrition 0.000 claims description 2
- 239000000196 tragacanth Substances 0.000 claims description 2
- 229940116362 tragacanth Drugs 0.000 claims description 2
- 229920001285 xanthan gum Polymers 0.000 claims description 2
- 239000008186 active pharmaceutical agent Substances 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 239000013585 weight reducing agent Substances 0.000 claims 1
- 238000000034 method Methods 0.000 description 9
- 150000001768 cations Chemical class 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 239000000499 gel Substances 0.000 description 7
- 239000008187 granular material Substances 0.000 description 5
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- -1 montmorillonites Chemical class 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 239000001110 calcium chloride Substances 0.000 description 3
- 229910001628 calcium chloride Inorganic materials 0.000 description 3
- 239000004227 calcium gluconate Substances 0.000 description 3
- 229960004494 calcium gluconate Drugs 0.000 description 3
- 235000013927 calcium gluconate Nutrition 0.000 description 3
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 3
- 230000032050 esterification Effects 0.000 description 3
- 238000005886 esterification reaction Methods 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 159000000003 magnesium salts Chemical class 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 229940081735 acetylcellulose Drugs 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000002156 adsorbate Substances 0.000 description 2
- 229940072056 alginate Drugs 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 239000002830 appetite depressant Substances 0.000 description 2
- 229910052788 barium Inorganic materials 0.000 description 2
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 229960005069 calcium Drugs 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 229920002301 cellulose acetate Polymers 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- YOZNUFWCRFCGIH-BYFNXCQMSA-L hydroxocobalamin Chemical compound O[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O YOZNUFWCRFCGIH-BYFNXCQMSA-L 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 229920000620 organic polymer Polymers 0.000 description 2
- 235000011837 pasties Nutrition 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- ZJAOAACCNHFJAH-UHFFFAOYSA-N phosphonoformic acid Chemical compound OC(=O)P(O)(O)=O ZJAOAACCNHFJAH-UHFFFAOYSA-N 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920002689 polyvinyl acetate Polymers 0.000 description 2
- 239000011118 polyvinyl acetate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 229940032147 starch Drugs 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- DBGIVFWFUFKIQN-UHFFFAOYSA-N (+-)-Fenfluramine Chemical compound CCNC(C)CC1=CC=CC(C(F)(F)F)=C1 DBGIVFWFUFKIQN-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N 2,3,4,5-tetrahydroxypentanal Chemical compound OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- JWUBBDSIWDLEOM-UHFFFAOYSA-N 25-Hydroxycholecalciferol Natural products C1CCC2(C)C(C(CCCC(C)(C)O)C)CCC2C1=CC=C1CC(O)CCC1=C JWUBBDSIWDLEOM-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- WNCAVNGLACHSRZ-KAMYIIQDSA-N Allithiamine Chemical compound C=CCSSC(/CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N WNCAVNGLACHSRZ-KAMYIIQDSA-N 0.000 description 1
- WNCAVNGLACHSRZ-UHFFFAOYSA-N Allithiamine Natural products C=CCSSC(CCO)=C(C)N(C=O)CC1=CN=C(C)N=C1N WNCAVNGLACHSRZ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- 235000021318 Calcifediol Nutrition 0.000 description 1
- 229920008347 Cellulose acetate propionate Polymers 0.000 description 1
- 229920002284 Cellulose triacetate Polymers 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- VWFCHDSQECPREK-LURJTMIESA-N Cidofovir Chemical compound NC=1C=CN(C[C@@H](CO)OCP(O)(O)=O)C(=O)N=1 VWFCHDSQECPREK-LURJTMIESA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 description 1
- BXZVVICBKDXVGW-NKWVEPMBSA-N Didanosine Chemical compound O1[C@H](CO)CC[C@@H]1N1C(NC=NC2=O)=C2N=C1 BXZVVICBKDXVGW-NKWVEPMBSA-N 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical group CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 206010014476 Elevated cholesterol Diseases 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 108010022355 Fibroins Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- ZPXSCAKFGYXMGA-UHFFFAOYSA-N Mazindol Chemical compound N12CCN=C2C2=CC=CC=C2C1(O)C1=CC=C(Cl)C=C1 ZPXSCAKFGYXMGA-UHFFFAOYSA-N 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001756 Polyvinyl chloride acetate Polymers 0.000 description 1
- NCDNCNXCDXHOMX-UHFFFAOYSA-N Ritonavir Natural products C=1C=CC=CC=1CC(NC(=O)OCC=1SC=NC=1)C(O)CC(CC=1C=CC=CC=1)NC(=O)C(C(C)C)NC(=O)N(C)CC1=CSC(C(C)C)=N1 NCDNCNXCDXHOMX-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 229920002433 Vinyl chloride-vinyl acetate copolymer Polymers 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- WREGKURFCTUGRC-POYBYMJQSA-N Zalcitabine Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](CO)CC1 WREGKURFCTUGRC-POYBYMJQSA-N 0.000 description 1
- SMEGJBVQLJJKKX-HOTMZDKISA-N [(2R,3S,4S,5R,6R)-5-acetyloxy-3,4,6-trihydroxyoxan-2-yl]methyl acetate Chemical compound CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O)OC(=O)C)O)O SMEGJBVQLJJKKX-HOTMZDKISA-N 0.000 description 1
- NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 230000035508 accumulation Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229960004150 aciclovir Drugs 0.000 description 1
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 125000005396 acrylic acid ester group Chemical group 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229940050528 albumin Drugs 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical group O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
- 229960002535 alfacalcidol Drugs 0.000 description 1
- OFHCOWSQAMBJIW-AVJTYSNKSA-N alfacalcidol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C OFHCOWSQAMBJIW-AVJTYSNKSA-N 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 229940121357 antivirals Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-UHFFFAOYSA-N beta-D-galactopyranuronic acid Natural products OC1OC(C(O)=O)C(O)C(O)C1O AEMOLEFTQBMNLQ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QRZGKKJRSA-N beta-cellobiose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QRZGKKJRSA-N 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- JWUBBDSIWDLEOM-DTOXIADCSA-N calcidiol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)CCC1=C JWUBBDSIWDLEOM-DTOXIADCSA-N 0.000 description 1
- 229960004361 calcifediol Drugs 0.000 description 1
- 229960005084 calcitriol Drugs 0.000 description 1
- 235000020964 calcitriol Nutrition 0.000 description 1
- 239000011612 calcitriol Substances 0.000 description 1
- GMRQFYUYWCNGIN-NKMMMXOESA-N calcitriol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-NKMMMXOESA-N 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229960000724 cidofovir Drugs 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000009194 citrus pectin Substances 0.000 description 1
- 229940040387 citrus pectin Drugs 0.000 description 1
- 238000005253 cladding Methods 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-YBSDWZGDSA-N d-mannuronic acid Chemical compound O[C@@H]1O[C@@H](C(O)=O)[C@H](O)[C@@H](O)[C@H]1O AEMOLEFTQBMNLQ-YBSDWZGDSA-N 0.000 description 1
- 229960002656 didanosine Drugs 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229960004890 diethylpropion Drugs 0.000 description 1
- XXEPPPIWZFICOJ-UHFFFAOYSA-N diethylpropion Chemical compound CCN(CC)C(C)C(=O)C1=CC=CC=C1 XXEPPPIWZFICOJ-UHFFFAOYSA-N 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- DLNKOYKMWOXYQA-UHFFFAOYSA-N dl-pseudophenylpropanolamine Natural products CC(N)C(O)C1=CC=CC=C1 DLNKOYKMWOXYQA-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 238000006266 etherification reaction Methods 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 229960004396 famciclovir Drugs 0.000 description 1
- GGXKWVWZWMLJEH-UHFFFAOYSA-N famcyclovir Chemical compound N1=C(N)N=C2N(CCC(COC(=O)C)COC(C)=O)C=NC2=C1 GGXKWVWZWMLJEH-UHFFFAOYSA-N 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- IQUFSXIQAFPIMR-UHFFFAOYSA-N fenproporex Chemical compound N#CCCNC(C)CC1=CC=CC=C1 IQUFSXIQAFPIMR-UHFFFAOYSA-N 0.000 description 1
- 229960005231 fenproporex Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229960005102 foscarnet Drugs 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229960002963 ganciclovir Drugs 0.000 description 1
- IRSCQMHQWWYFCW-UHFFFAOYSA-N ganciclovir Chemical compound O=C1NC(N)=NC2=C1N=CN2COC(CO)CO IRSCQMHQWWYFCW-UHFFFAOYSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 239000010514 hydrogenated cottonseed oil Substances 0.000 description 1
- 235000004867 hydroxocobalamin Nutrition 0.000 description 1
- 239000011704 hydroxocobalamin Substances 0.000 description 1
- 229960001103 hydroxocobalamin Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 125000001905 inorganic group Chemical group 0.000 description 1
- 208000003243 intestinal obstruction Diseases 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 229960001627 lamivudine Drugs 0.000 description 1
- JTEGQNOMFQHVDC-NKWVEPMBSA-N lamivudine Chemical compound O=C1N=C(N)C=CN1[C@H]1O[C@@H](CO)SC1 JTEGQNOMFQHVDC-NKWVEPMBSA-N 0.000 description 1
- JCRIVQIOJSSCQD-VIFPVBQESA-N levopropylhexedrine Chemical compound CN[C@@H](C)CC1CCCCC1 JCRIVQIOJSSCQD-VIFPVBQESA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229960000299 mazindol Drugs 0.000 description 1
- 229960001468 mefenorex Drugs 0.000 description 1
- XXVROGAVTTXONC-UHFFFAOYSA-N mefenorex Chemical compound ClCCCNC(C)CC1=CC=CC=C1 XXVROGAVTTXONC-UHFFFAOYSA-N 0.000 description 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
- KBHMHROOFHVLBA-UHFFFAOYSA-N metamfepramone Chemical compound CN(C)C(C)C(=O)C1=CC=CC=C1 KBHMHROOFHVLBA-UHFFFAOYSA-N 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 125000001483 monosaccharide substituent group Chemical group 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 235000019175 phylloquinone Nutrition 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 1
- 239000011772 phylloquinone Substances 0.000 description 1
- 229960001898 phytomenadione Drugs 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920001281 polyalkylene Polymers 0.000 description 1
- 229920000867 polyelectrolyte Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960000311 ritonavir Drugs 0.000 description 1
- NCDNCNXCDXHOMX-XGKFQTDJSA-N ritonavir Chemical compound N([C@@H](C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1SC=NC=1)CC=1C=CC=CC=1)C(=O)N(C)CC1=CSC(C(C)C)=N1 NCDNCNXCDXHOMX-XGKFQTDJSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229910052814 silicon oxide Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229920003109 sodium starch glycolate Polymers 0.000 description 1
- 229940079832 sodium starch glycolate Drugs 0.000 description 1
- 239000008109 sodium starch glycolate Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229920006163 vinyl copolymer Polymers 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 229960000523 zalcitabine Drugs 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 229960002555 zidovudine Drugs 0.000 description 1
- HBOMLICNUCNMMY-XLPZGREQSA-N zidovudine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-XLPZGREQSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/231—Pectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/25—Exudates, e.g. gum arabic, gum acacia, gum karaya or tragacanth
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/256—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seaweeds, e.g. alginates, agar or carrageenan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/262—Cellulose; Derivatives thereof, e.g. ethers
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/269—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
- A23L29/27—Xanthan not combined with other microbial gums
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/275—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of animal origin, e.g. chitin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Dispersion Chemistry (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Die vorliegende Erfindung betrifft ein Mittel zur Erzeugung eines Sättigungseffekts, zur Gewichtsreduktion und zur Regulierung des Cholesterinhaushalts.The present invention relates to a means of producing a saturation effect, for weight loss and regulating cholesterol levels.
Es sind zahlreiche Versuche unternommen worden, auf medikamentösem Weg überflüssige Fettanreicherungen im menschlichen Körper abzubauen beziehungsweise deren Entstehung zu verhindern. Es gibt z.B. sogenannte Appetitzügler, die den Körper auf biochemischem Weg eine Abneigung zur Nahrungsaufnahme zu suggerieren versuchen. Diese Mittel haben zum Teil erhebliche schädliche Nebenwirkungen.Numerous attempts have been made on medication Get rid of unnecessary fat accumulations in the human body to dismantle or prevent their formation. There are e.g. so-called appetite suppressants, the body to suggest an aversion to food in a biochemical way to attempt. Some of these remedies have considerable harmful side effects.
Neben den zahlreichen bekannten Diätvorschlägen gibt es auch mechanische und elektromechanische Mittel, mit denen ein gezielter Fettabbau beziehungsweise Muskelaufbau erfolgen soll. Die Wirkung solcher Mittel ist jedoch sehr zweifelhaft.In addition to the numerous known diet proposals it also mechanical and electromechanical means with which a targeted fat loss or muscle building. However, the effect of such funds is very doubtful.
Aus der
Ferner sind aus
Aufgrund des ständig steigenden Gesundheitsbewußtseins ist jedoch eine weitere Verbesserung von Mitteln zur Erzeugung eines Sättigungseffekts von hoher medizinischer und wirtschaftlicher Relevanz.Because of the ever increasing health awareness however, is a further improvement in means of generating a saturation effect of high medical and economic relevance.
Aufgabe der vorliegenden Erfindung ist es, ein verbessertes Mittel zur oralen Einnahme zur Verfügung zu stellen, das eine höhere Magenverweilzeit aufweist als bekannte Mittel seiner Art und dadurch zu einem effektiveren Sättigungseffekt führt. Ferner sollte es zur Gewichtsreduzierung unter gleichzeitiger Regulierung des Cholesterinspiegels geeignet sein, da Übergewichtigkeit in der Regel mit einem überhöhten Cholesterinspiegel einhergeht. Darüber hinaus ist eine einfache Herstellung aus preiswerten Rohstoffen wünschenswert, die keine gesundheitlichen Risiken in sich bergen.Object of the present invention is an improved oral intake available too make that a higher Stomach dwell time is known as a means of its kind and thereby a more effective satiety effect leads. It should also help reduce weight while regulating it of cholesterol may be appropriate because obesity is usually with high cholesterol accompanied. Furthermore simple manufacture from inexpensive raw materials is desirable, that have no health risks.
Die vorliegende Aufgabe wird durch ein Mittel zur Erzeugung eines Sättigungseffektes, zur Gewichtsreduktion und zur Cholesterinsenkung enthaltend niederveresterte Polysaccharide und wenigstens eine weitere hiervon verschiedene Verbindung, die quellfähig ist, ausgenommen Aluminiumsalze von anionischen Polymeren, gelöst.The task at hand is accomplished by a means of producing a saturation effect, for weight loss and for lowering cholesterol containing low-esterified Polysaccharides and at least one other different from them Connection that swells is dissolved, with the exception of aluminum salts of anionic polymers.
Als niederveresterte Polysaccharide kommen niederveresterte Pectine, Xanthan, Tragant, Chondroitsulfat vorzugsweise zum Einsatz.As low-esterified polysaccharides come low-esterified pectins, xanthan, tragacanth, chondroite sulfate preferably used.
Hinsichtlich der niederveresterten Polymere ist auch der Einsatz niederveresterter Pektine erfindungsgemäß besonders bevorzugt. Pektine bestehen aus Ketten von α-1,4-glykosidisch verbundenen Galakturonsäure-Einheiten, deren Säuregruppen zu 20-80% mit Methanol verestert sind. Man unterscheidet zwischen hochveresterten (> 50%) und niedegveresterten (< 50%) Pektinen. Die Molmasse variiert zwischen 10-500 kDa. Die Gewinnung von Pektinen erfolgt durch saure Extraktion mit an sich bekannten Methoden gemäß dem Stand der Technik aus den inneren Anteilen von Citrusfruchtschalen, Obsttrestern oder Zuckerrübenschnitzeln. Die resultierenden Pektine (Apfel-Pektin, Citrus-Pektin) sind somit rein pflanzlich und weisen eine hohe Biokompatibilität auf. Sie können unter Wasseraufnahme Gele bilden.With regard to the low esterification Polymers, the use of low-ester pectins is also special according to the invention prefers. Pectins consist of chains of α-1,4-glycosidically linked galacturonic acid units, their acid groups are esterified to 20-80% with methanol. One distinguishes between highly esterified (> 50%) and low esterification (<50%) Pectins. The molar mass varies between 10-500 kDa. Pectins are obtained by acidic extraction using methods known per se according to the prior art the technology from the inner parts of citrus fruit peel, fruit pulp or Sugar beet pulp. The resulting pectins (apple pectin, citrus pectin) are thus purely vegetable and have a high biocompatibility. she can Form gels while absorbing water.
Auch hier ist der Einsatz von Pektingelen in Gegenwart zweiwertiger Kationen, wie Calcium oder Barium bekannt. Letzteres ist auch hier aufgrund seiner Toxizität für den Einsatz in Biomedizin jedoch nicht geeignet. Neben Calcium-Chlorid liefert auch Calcium-Glukonat geeignete zweiwertige Kationen. Denkbar ist auch der Einsatz von Magnesium-Salzen oder eine Mischung verschiedener physiologisch unbedenklicher zweiwertiger Kationen.Here too is the use of pectin gels in the presence of divalent cations, such as calcium or barium. The latter is also here due to its toxicity for use in biomedicine however not suitable. In addition to calcium chloride, calcium gluconate also provides suitable divalent cations. The use of magnesium salts or is also conceivable a mixture of different physiologically harmless divalent Cations.
Der erfindungsgemäße Einsatz von Pektinen zeichnet sich in vorteilhafter Weise dadurch aus, daß diese cholesterinsenkende Eigenschaften besitzen. Diese Eigenschaft ist im Sinne der vorliegenden Erfindung von Vorteil, da Übergewicht in der Regel mit einem erhöhten Cholesterinspiegel einhergeht.The use of pectins according to the invention draws is advantageously characterized in that this lowers cholesterol Possess properties. This property is in the sense of the present Invention advantageous because overweight usually with an elevated Cholesterol levels.
Neben den beschriebenen niederveresterten Polysacchariden ist in dem erfindungsgemäßen Mittel wenigstens eine weitere Verbindung enthalten, die quellfähig ist. Hierfür können zum Beispiel anorganische Stoffe wie MgCl2, CaSO4,: Na2CO3, CaCO3, Polykieselsäuren und Tonmineralien (wie Montmorillonite, Zeolithe, Kieselsäuren) oder organische Stoffe wie Mono- und/oder Disaccharide (Mannose, Glucose, Sucrose, Sorbit), Lactose, Weinsäure oder Harnstoff eingesetzt werden.In addition to the low-esterified polysaccharides described, the agent according to the invention contains at least one further compound which is capable of swelling. For this purpose, for example, inorganic substances such as MgCl 2 , CaSO 4 ,: Na 2 CO 3 , CaCO 3 , polysilicic acids and clay minerals (such as montmorillonites, zeolites, silicas) or organic substances such as mono- and / or disaccharides (mannose, glucose, sucrose, Sorbitol), lactose, tartaric acid or urea.
In einer Ausführung der vorliegenden Erfindung werden organische Polymere eingesetzt, bevorzugt solche die als Polyelektrolyte fungieren. Organische Polymere können bezüglich ihres Ursprungs beziehungsweise Synthese natürlich, halbsynthetisch oder synthetisch sein. Beispiele geeigneter Polymere sind Polyurethane, Polyacrylate, Poly(met)acrylsäureester, Homo- und Copolymere des Vinylacetats, Polyvinylacetat, Polyacrylsäure, Polyethylenglykol, Polyvinylpyrrolidon, Cellulose, Ether, Diethylcellulose oder Celluloseester, wie Cellulosediacetat, Cellulosetriacetat, Celluloseacetat-Propionat und Celluloseacetat, Methylcellulose, Hydroxypropylcellulose, Hydroxypropyl-methylcellulose, oder Natriumcarboxymethylcellulose (vorzugsweise solche Verbindungen mit höherer Viskosität); Butyrat, nieder substituierte Hydroxypropylcellulose, Carboxymethylcellulose (mit 2- oder 3-wertigen Kationen), Na-Stärkeglykolat, Glykosaminglykane wie Chondroitinsulfat oder Hyaluronsäure, Collagen, Albumin, Keratine, Conchagene, Fibroin, Elastine, Chitin.In one embodiment of the present invention, organic polymers are used, preferably those which act as polyelectrolytes. Organic polymers can be natural, semi-synthetic or synthetic with regard to their origin or synthesis. Examples of suitable polymers are polyurethanes, polyacrylates, poly (met) acrylic esters, homo- and copolymers of vinyl acetate, polyvinyl acetate, polyacrylic acid, polyethylene glycol, polyvinyl pyrrolidone, cellulose, ether, diethyl cellulose or cellulose esters, such as cellulose di acetate, cellulose triacetate, cellulose acetate propionate and cellulose acetate, methyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose, or sodium carboxymethyl cellulose (preferably those compounds with higher viscosity); Butyrate, low-substituted hydroxypropyl cellulose, carboxymethyl cellulose (with 2 or 3-valent cations), sodium starch glycolate, glycosaminoglycans such as chondroitin sulfate or hyaluronic acid, collagen, albumin, keratin, conchagens, fibroin, elastins, chitin.
Bevorzugt werden Hydrokolloide, besonders bevorzugt auf Basis von Polysacchariden, eingesetzt.Hydrocolloids are preferred, particularly preferred based on polysaccharides.
Besonders bevorzugt ist der Einsatz von anionischen Polymeren. Hierzu zählen vorzugsweise Polysaccharide, insbesondere Polyuronsäure-haltige Polysaccharide. Besonders bevorzugt sind Alginsäuren, deren Derivate und Salze (Alginate). In einer bevorzugten Variante der Erfindung kommen alle anionischen Polymere mit Ausnahme der Aluminiumsalze in Betracht. Insbesondere sind die Aluminiumsalze der Alginsäuren jedoch ausgenommen. Aber auch alle anderen Uronsäure-haltigen Verbindungen können erfindungsgemäß zum Einsatz kommen. Erfindungsgemäß bevorzugt ist ferner der Einsatz von Cellulose oder Cellulosederivaten. Denkbar ist die Verwendung von synthetischen oder halbsynthetischen Cellulosederivaten, wie z.B. Carboxymethylcellulose oder von Polyacrylaten.Use is particularly preferred of anionic polymers. These preferably include polysaccharides, in particular polysaccharides containing polyuronic acid. Algic acids are particularly preferred, their derivatives and salts (alginates). In a preferred variant All anionic polymers except the Aluminum salts into consideration. In particular, the aluminum salts are the alginic however excluded. However, all other uronic acid-containing compounds can also be used according to the invention come. Preferred according to the invention is also the use of cellulose or cellulose derivatives. Conceivable is the use of synthetic or semi-synthetic cellulose derivatives, such as. Carboxymethyl cellulose or polyacrylates.
Unter Cellulose sind wasserunlösliche Polysaccharide der Bruttozusammensetzung (C6H10O5)n zu verstehen. Genauer gesagt handelt es sich um ein isotaktisches β-1,4-Polyacetal von Cellobiose (4-O-β-D-Glucopyranosyl-D-glucose).Cellulose means water-insoluble polysaccharides with a gross composition (C 6 H 10 O 5 ) n . More specifically, it is an isotactic β-1,4-polyacetal of cellobiose (4-O-β-D-glucopyranosyl-D-glucose).
Als Cellulosederivate werden im allgemeinen durch polymeranaloge Reaktionen chemisch modifizierte Cellulosen definiert. Sie umfassen sowohl Produkte, bei denen ausschließlich, z.B. über Veresterungs- und/oder Veretherungsreaktionen, Hydroxy-Wasserstoffatome der Anhydroglucose-Einheiten der Cellulose durch organische oder anorganische Gruppen substituiert sind, als auch solche, die unter formalem Austausch von Hydroxy-Gruppen der natürlichen Polymeren gegen funktionelle Gruppen, die nicht über ein Sauerstoffatom gebunden sind (z.B. Desoxycellulosen) bzw. über intramolekulare Wasserabspaltung (Anhydrocellulosen, Cellulosen) oder Oxidationsreaktionen (Aldehyd-, Keto- und Carboxycellulosen) gebildet werden. Auch Produkte, die unter Spaltung der C2,C3-Kohlenstoff-Bindung der Anhydroglucose-Einheiten anfallen (Dialdehyd- u. Dicarboxycellulosen), bei denen also die für die Cellulose charakteristischen Monomereinheit nicht mehr in Takt ist, werden zu den Cellulosederivaten gerechnet. Cellulosederivate sind auch über andere Reaktionen zugänglich, z.B. über Vernetzung- oder Pfropfcopolymerisations-Reaktionen.Chemically modified celluloses are generally defined as cellulose derivatives by polymer-analogous reactions. They include both products in which hydroxyl-hydrogen atoms of the anhydroglucose units of cellulose are substituted by organic or inorganic groups exclusively, for example via esterification and / or etherification reactions, as well as those with formal exchange of hydroxyl groups of the natural polymers against functional groups that are not bound via an oxygen atom (eg deoxycelluloses) or via intramolecular elimination of water (anhydrocelluloses, celluloses) or oxidation reactions (aldehyde, keto and carboxycelluloses). Products which cleave the C 2, C 3 carbon bond of the anhydroglucose units (dialdehyde and dicarboxy celluloses) and in which the monomer unit characteristic of the cellulose is no longer intact are also included in the cellulose derivatives. Cellulose derivatives are also accessible via other reactions, for example via crosslinking or graft copolymerization reactions.
Erfindungsgemäß vorteilhaft ist der Einsatz von Cellulose oder Cellulosederivaten in Gemisch mit Pectinen. Ebenso sind Mischungen enthaltend Alginsäure oder deren Derivate, wobei vorzugsweise Aluminiumsalze der Alginsäuren ausgenommen und Pektine bevorzugt sind.The use of is advantageous according to the invention Cellulose or cellulose derivatives in a mixture with pectins. As well are mixtures containing alginic acid or its derivatives, where preferably excluding aluminum salts of alginic acids and pectins are preferred.
Alginsäure ist eine lineare Polyuronsäure aus wechselnden Anteilen von D-Mannuronsäure und L-Guluronsäure, die durch β-glykosidische Bindungen miteinander verknüpft sind, wobei die Carboxylgruppen nicht verestert sind. Ein Molekül Alginsäure kann sich aus etwa 150-1050 Uronsäure-Einheiten zusammensetzen, wobei das durchschnittliche Molekulargewicht in einem Bereich von 30-200 kDa variieren kann.Alginic acid is a linear polyuronic acid changing proportions of D-mannuronic acid and L-guluronic, by β-glycosidic Bonds linked together are, wherein the carboxyl groups are not esterified. One molecule of alginic acid can consists of approximately 150-1050 uronic acid units with the average molecular weight in can vary in a range of 30-200 kDa.
Das Polysaccharid Alginsäure ist ein Bestandteil der Zellwänden von Braunalgen. Der Anteil der Alginsäure an der Trockenmasse der Algen kann hierbei bis zu 40% ausmachen. Die Gewinnung der Alginsäure erfolgt durch alkalische Extraktion mit an sich bekannten Methoden gemäß dem Stand der Technik. Die resultierende pulverförmige Alginsäure ist somit rein pflanzlich und weist eine hohe Biokompatibilität auf. Sie kann unter Bildung hochviskoser Lösungen die 300-fache Menge ihres Eigengewichtes an Wasser aufnehmen. In Gegenwart von mehrwertigen Kationen bildet Alginsäure sogenannte Gele. Die Bildung von Alginatgelen in Gegenwart zweiwertiger Kationen, wie Calcium oder Barium, sind bei Shapiro I., et al. (Biomaterials, 1997, 18: 583-90) beschrieben. Letzteres ist aufgrund seiner Toxizität für den Einsatz in Biomedizin jedoch nicht geeignet. Neben Calcium-Chlorid liefert auch Calcium-Glukonat geeignete zweiwertige Kationen. Denkbar ist auch der Einsatz von Magnesium-Salzen oder eine Mischung verschiedener physiologisch unbedenklicher zweiwertiger Kationen.The polysaccharide is alginic acid a component of the cell walls of brown algae. The proportion of alginic acid in the dry mass of Algae can make up to 40% of this. The alginic acid is obtained by alkaline extraction using methods known per se according to the prior art of the technique. The resulting powdered alginic acid is thus purely vegetable and has a high biocompatibility. she can form 300 times the amount with formation of highly viscous solutions absorb their own weight in water. In the presence of multivalent Cations form alginic acid so-called gels. The formation of alginate gels in the presence of divalent Cations such as calcium or barium are described in Shapiro I., et al. (Biomaterials, 1997, 18: 583-90). The latter is due to its toxicity for use not suitable in biomedicine. In addition to calcium chloride also supplies Calcium gluconate suitable divalent cations. That is also conceivable Use of magnesium salts or a mixture of different physiological harmless divalent cations.
Das erfindungsgemäße Mittel weist die beschriebenen Verbindungen vorzugsweise in pulverförmiger Ausführungsform auf. D.h., das Mittel kann als Adsorbat, Beadlet-Pulver, Granulat, Pellet, Extrudat und/oder Kombinationen davon vorliegen. Ebenso sind Einsatzformen denkbar, bei denen die Partikel beschichtet sind.The agent according to the invention has the described Compounds preferably in powdered form. That is, the mean can be used as adsorbate, beadlet powder, Granules, pellets, extrudates and / or combinations thereof are present. Use forms in which the particles are coated are also conceivable are.
Die Herstellung der erfindungsgemäß vorzugsweise
in Pulverform vorliegenden Mittel kann mit an sich bekannten Methoden
erfolgen. Hierzu zählt beispielsweise
die Herstellung von Sprühformulierungen.
Ein einsetzbares Verfahren und Aggregat hierfür sind beispielsweise in der
Neben dieser Herstellungsart sind auch weitere Verfahrensvarianten denkbar. Hierzu zählen z.B. Sprühtrocknungsprozesse oder die Herstellung von Adsorbaten in Wirbelschichten.In addition to this type of manufacture other process variants are also conceivable. These include e.g. Spray drying processes or the production of adsorbates in fluidized beds.
Zur Herstellung eines pulverförmigen erfidungsgemäßen Mittels kann beispielsweise eine Lösung der niederveresterten Polymere in Wasser hergestellt und z.B. unter Zugabe von Calciumsalzen eingedickt werden. Durch Einarbeiten von Luft und ggf. nach Zugabe von Tensiden kann ein Gel oder Schaum erhalten werden. Durch Einfrieren und anschließendes Gefriertrocknen wird aus dem Alginatgel oder -schaum ein Trockengel oder Trockenschaum (Schwamm) hergestellt. Die Herstellung der weiteren Verbindungen, die erfindungsgemäß quellfähig sein müssen, kann in analoger Weise erfolgen.To produce a powdery agent according to the invention, for example, a solution of the lower esterified polymers in water can be prepared and thickened, for example, with the addition of calcium salts. A gel or foam can be obtained by incorporating air and possibly adding surfactants. By freezing and then freeze-drying the alginate gel or foam a dry gel or dry foam (sponge) is made. The other compounds, which must be swellable according to the invention, can be prepared in an analogous manner.
Neben der Zugabe von anorganischen oder organischen Calciumsalzen, wie z.B. Calciumchlorid oder Calciumglukonat, ist auch die Verwendung von Magnesiumsalzen denkbar sowie von Mischungen verschiedener physiologisch unbedenklicher zweiwertiger oder dreiwertiger Kationen.In addition to the addition of inorganic or organic calcium salts, e.g. Calcium chloride or calcium gluconate, it is also conceivable to use magnesium salts and mixtures of different ones physiologically harmless divalent or trivalent cations.
Die Herstellung von Granulaten kann dadurch erreicht werden, dass in einem Mischer Trägerstoffe und/oder sprühgetrocknete Pulver sowie ggf. Zuschlagsstoffe vorgelegt und durch Zugabe der Wirkkomponenten und/oder Binder und/oder Zuschlagsstoffe kompakte Granulate erzeugt werden. In diesem Verfahren vorzugsweise eingesetzte Mischer sind z.B. Schaufelmischer oder Pflugscharmischer. Die flüssigen Komponenten können beispielsweise aufgetropft oder aufgesprüht werden, so dass eine pastöse, klebrige Phase entsteht. Über geeignete Wahl der Drehzahl der Mischwerkzeuge und/oder schnelllaufenden Messern wird die pastöse Phase verteilt und es entstehen kompakte Granulate. Sehr große Brocken werden durch Mischwerkzeuge und Messer zerteilt und andererseits feine Pulver agglomeriert. Durch Zugabe von Hüllschichten kann nachgeschaltet im Mischer bei geringerer Drehzahl der Mischwerkzeuge und stehenden Messer oder in einem bauartverwandten nachgeschalteten Mischer erfolgen.The production of granules can can be achieved by using carriers in a mixer and / or spray dried Powder and, if necessary, aggregates are submitted and by adding the active components and / or binders and / or additives produce compact granules become. Mixers are preferably used in this process e.g. Paddle mixer or ploughshare mixer. The liquid components can be dropped or sprayed on, for example, so that a pasty, sticky Phase arises. about suitable choice of the speed of the mixing tools and / or high-speed Knives become the pasty phase distributed and compact granules are formed. Very big chunks are cut up by mixing tools and knives and on the other hand fine powder agglomerated. By adding cladding layers can be added in the mixer at lower speed of the mixing tools and stationary Knives or in a design-related downstream mixer.
Das erfindungsgemäße Mittel kann in verschiedenen üblichen Darreichungsformen hergestellt werden. So kann es beispielsweise in Form von Tabletten, Kapseln, Dragees, als Granulat oder Pulver oder anderen Ausgestaltungen vorliegen.The agent according to the invention can be used in various conventional ways Dosage forms are produced. For example, it can in the form of tablets, capsules, dragees, as granules or powder or other configurations are available.
Das erfindungsgemäße Mittel kann auch weitere Hilfsstoffe und/oder Wirkstoffe enthalten.The agent according to the invention can also be other Contain auxiliary substances and / or active substances.
Unter „Hilfsstoffen" sind beispielsweise folgende Substanzen zu verstehen, die jedoch nicht limitierend für die vorliegende Erfindung sind: wasserunlösliche Hilfsstoffe oder Gemische davon, wie Lipide, u.a. Fettalkohole, z.B. Cetylalkohol, Stearylalkohol und Cetostearylalkohol; Glyceride, z.B. Glycerinmonostearat oder Gemische von Mono-, Di- und Triglyceriden pflanzlicher Öle; hydrierte Öle, wie hydriertes Rizinusöl oder hydriertes Baumwollsamenöl; Wachse, z.B. Bienenwachs oder Carnaubawachs; feste Kohlenwasserstoffe, Z.B. Paraffin oder Erdwachs; Fettsäuren, z.B. Stearinsäure; gewisse Cellulosederivate, z.B. Ethylcellulose oder Acetylcellulose; Polymere oder Copolymere, wie Polyalkylene, z.B. Polyäthylen, Polyvinylverbindungen, z.B. Polyvinylchlorid oder Polyvinylacetat, sowie Vinylchlorid-Vinylacetat-Copolymere und Copolymere mit Crotonsäure, oder Polymere und Copolymere von Acrylaten und Methacrylaten, z.B. Copolymerisate von Acrylsäureester und Methacrylsäuremethylester; oder Tenside, wie z.B. Polysorbat 80 oder Docusat.Under "auxiliaries" are, for example to understand the following substances, which, however, are not limiting for the present Invention are: water-insoluble Excipients or mixtures thereof, such as lipids, etc. Fatty alcohols, e.g. Cetyl alcohol, stearyl alcohol and cetostearyl alcohol; glycerides e.g. Glycerol monostearate or mixtures of mono-, di- and triglycerides vegetable oils; hydrogenated oils, like hydrogenated castor oil or hydrogenated cottonseed oil; waxes, e.g. Beeswax or carnauba wax; solid hydrocarbons, e.g. Paraffin or earth wax; fatty acids, e.g. stearic acid; certain cellulose derivatives, e.g. Ethyl cellulose or acetyl cellulose; polymers or copolymers such as polyalkylenes, e.g. Polyethylene, polyvinyl compounds, e.g. Polyvinyl chloride or polyvinyl acetate, as well as vinyl chloride-vinyl acetate copolymers and copolymers with crotonic acid, or polymers and copolymers of acrylates and methacrylates, e.g. Copolymers of acrylic acid esters and methyl methacrylate; or surfactants, e.g. Polysorbate 80 or Docusat.
Unter „Wirkstoffen" sind beispielsweise
Vitamine, Spurenelemente oder Arzneiwirkstoffe zu verstehen. Folgende
Substanzen sind beispielhaft aufgezählt, die jedoch nicht limitierend
für die
vorliegende Erfindung sind:
Beispiele für Appetitzügler sind: Amfepramon, Fenfluramin,
Fenproporex, Levopropylhexedrin, Mazindol, Mefenorex, Metamfepramon,
Norephedrin, Norpseudoephedrin.“Active ingredients” are to be understood to mean, for example, vitamins, trace elements or medicinal active ingredients. The following substances are listed by way of example, but are not limiting for the present invention:
Examples of appetite suppressants are: Amfepramon, Fenfluramin, Fenproporex, Levopropylhexedrin, Mazindol, Mefenorex, Metamfepramon, Norephedrin, Norpseudoephedrin.
Beispiele für Virustatika sind: Aciclovir, Cidofovir, Didanosin, Famciclovir, Foscarnet, Ganciclovir, Lamivudin, Ritonavir, Zalcitabin, Zidovudin.Examples of antivirals are: acyclovir, Cidofovir, didanosine, famciclovir, foscarnet, ganciclovir, lamivudine, Ritonavir, zalcitabine, zidovudine.
Beispiele für Vitamine sind: Alfacalcidol, Allithiamine, Ascorbinsäure, Biotin, Calcifediol, Calcitriol, Colecalciferol, Cyanocobalamin, Ergocalciferol, Folsäure, Hydroxocobalamin, Nicotinamid, Pantothensäure, Phytomenadion, Pyridoxin, Retinol, Riboflavin, Thiamin, Tocopherol, Transcalcifediol.Examples of vitamins are: alfacalcidol, Allithiamine, ascorbic acid, Biotin, calcifediol, calcitriol, colecalciferol, cyanocobalamin, Ergocalciferol, folic acid, Hydroxocobalamin, nicotinamide, pantothenic acid, phytomenadione, pyridoxine, Retinol, riboflavin, thiamine, tocopherol, transcalcifediol.
Unter Umständen kann hier zusätzlich eine retardierende Wirkstofffreisetzung erfolgen.Under certain circumstances, a retarding can also be used here Active ingredient release.
Außer den genannten Hilfsstoffen und Wirkstoffen kann das erfindungsgemäße Mittel zusätzlich Füll- Spreng-, Binde- und Gleitmittel sowie Trägerstoffe enthalten, die auf die Wirkstoftabgabe keinen entscheidenden Einfluß haben. Beispiele sind u.a. Bentonit (Aluminiumoxid-Siliciumoxid-hydrat), Kieselsäure, Cellulose (üblicherweise mikrokristalline Cellulose) oder Cellulosederivate, z.B. Methylcellulose, Natriumcarboxymethylcellulose, Zucker, wie Lactose, Stärken, z.B. Maisstärke oder Derivate davon, z.B. Natriumcarboxymethylstärke, Stärkeleister, Phosphorsäuresalze, z.B. Di- oder Tricalcioumphosphat, Gelatine, Stearinsäure oder geeignete Salze davon, z.B. Magnesiumstearat oder Calciumstearat, Talk, kollodiales Siliciumoxid und ähnliche Hilfsstoffe.Except for the additives mentioned and active ingredients, the agent according to the invention can additionally fill, detonate, Binders, lubricants and carriers contain, which have no decisive influence on the drug delivery. Examples include Bentonite (alumina-silica hydrate), silica, Cellulose (usually microcrystalline cellulose) or cellulose derivatives, e.g. Methylcellulose, Sodium carboxymethyl cellulose, sugars such as lactose, starches e.g. corn starch or derivatives thereof, e.g. Sodium carboxymethyl starch, starch paste, phosphoric acid salts, e.g. Di- or tricalcium phosphate, gelatin, stearic acid or suitable salts thereof, e.g. Magnesium stearate or calcium stearate, talc, colloidal silicon oxide and the like Excipients.
Das erfindungsgemäße Mittel kann zur Erzeugung eines Sättigungseffektes, zur Gewichtsreduktion und zur Regulierung des Cholesterinhaushalts eingesetzt werden. Außerdem ist es zur Herstellung einer Zusammensetzung zur Erzeugung eines Sättigungseffektes, zur Gewichtsreduktion und zur Regulierung des Cholesterinhaushalts geeignet.The agent according to the invention can be used for production a saturation effect, for weight loss and regulating cholesterol levels be used. Moreover it is used to make a composition to produce a Saturation effect, for weight loss and regulating cholesterol levels suitable.
Demgemäß kann das Mittel noch die Darmtätigkeit stimulierende Stoffe enthalten. Insbesondere kommen hier unverdauliche, jedoch die Darmtätigkeit fördernde Stoffe, vorzugsweise pflanzliche Naturbestandteile in Betracht. Beispiele hierfür sind Ballaststoffe.Accordingly, the agent can still bowel movements contain stimulating substances. In particular, indigestible however the bowel activity promotional Substances, preferably herbal natural ingredients. Examples of this are fiber.
Claims (11)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10259506A DE10259506A1 (en) | 2002-12-19 | 2002-12-19 | Appetite-and cholesterol-reducing agent comprises a low esterified polysaccharide and a different material which is swellable |
AU2003293907A AU2003293907A1 (en) | 2002-12-19 | 2003-12-17 | Agent for decreasing appetite and for producing a satiation effect, for reducing weight and for lowering the cholesterol level |
PCT/EP2003/014380 WO2004056375A1 (en) | 2002-12-19 | 2003-12-17 | Agent for decreasing appetite and for producing a satiation effect, for reducing weight and for lowering the cholesterol level |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10259506A DE10259506A1 (en) | 2002-12-19 | 2002-12-19 | Appetite-and cholesterol-reducing agent comprises a low esterified polysaccharide and a different material which is swellable |
Publications (1)
Publication Number | Publication Date |
---|---|
DE10259506A1 true DE10259506A1 (en) | 2004-07-08 |
Family
ID=32477794
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE10259506A Withdrawn DE10259506A1 (en) | 2002-12-19 | 2002-12-19 | Appetite-and cholesterol-reducing agent comprises a low esterified polysaccharide and a different material which is swellable |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE10259506A1 (en) |
-
2002
- 2002-12-19 DE DE10259506A patent/DE10259506A1/en not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1494655A1 (en) | Agent for producing a sensation of satiety and for weight loss | |
DE602004003577T2 (en) | Floating oral formulations with controlled release of betaine | |
WO2003053451A1 (en) | Use of ionic and non-ionic cellulose ethers for producing a gel-like agent for preventing the resorption of fats from the gastro-intestinal tract | |
WO2001017377A1 (en) | Cross-linked agent for generation of a long-lasting satiety effect and method for the production of the said | |
EP0948316B1 (en) | Agent for producing a long-lasting saturation effect | |
WO2004056375A1 (en) | Agent for decreasing appetite and for producing a satiation effect, for reducing weight and for lowering the cholesterol level | |
DE10259506A1 (en) | Appetite-and cholesterol-reducing agent comprises a low esterified polysaccharide and a different material which is swellable | |
EP1572238A1 (en) | Agent with a retarded release of substances | |
DE19942417A1 (en) | Orally administered composition for obtaining satiation effect and/or improving gastric function, containing crosslinked uronic acid-containing polysaccharide in sponge form | |
DE10216551A1 (en) | Orally administered composition for obtaining satiation effect, reducing body weight and regulating cholesterol levels, comprising dried porous gel or foam of anionic polymer in aluminum salt form | |
DE10258993A1 (en) | Composition for long-term repletion, reducing the appetite or wt. reduction in children contains locust bean flour and a fatty acid or derivative | |
DE10044846A1 (en) | Agent with prolonged gastric residence time to produce a long-lasting satiety effect and its use | |
WO2004056199A1 (en) | Preparation for reducing the appetite, producing a satiated feeling and/or for weight loss in children | |
DE19838794A1 (en) | Composition for the treatment of osteoarthritis and for the nutritional treatment of articular cartilage | |
DE10259503A1 (en) | Production of a composition for oral ingestion, useful for producing pharmaceutical or food products, comprises coating a polymer powder with a hydrophilic liquid | |
WO2004056339A1 (en) | Method for producing agents which are to be administered orally and corresponding compositions using polymers and coatings thereof consisting of hydrophilic liquids | |
WO2005021038A2 (en) | Agent for treating metabolic syndrome | |
CN102671203B (en) | Undaria pinnatifida polysaccharides tablet excipient, drug tablet and preparation method of drug tablet | |
DE10339354A1 (en) | Synergistic composition for treating metabolic syndrome, comprises swellable or gel-forming satiating and weight reducing agent and hypocholesterolemic and/or antidiabetic agent | |
DE102009012788A1 (en) | Compressible tablet material with oily agent, tablet and method and apparatus for their preparation | |
EP3387916B1 (en) | Edible composition for digestive promotion | |
DE10339863A1 (en) | Source substrate pellets as an oral dosage form for fiber | |
DE10120748A1 (en) | Antiallergic condom has a structurally-nonhomogeneous lubricating coating slurry containing swollen soft polyelectrolyte particles containing a biopolymer and chitosan or a derivative | |
DE1617845C (en) | Depot medicine in capsule form | |
EP1210071A1 (en) | Method for improving and maintaining bowel function as well as a method for the production thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OP8 | Request for examination as to paragraph 44 patent law | ||
8139 | Disposal/non-payment of the annual fee |